ACE inhibitors, ARBs kindle interest to repurpose for Covid-19; potential risk apparent

Covid-19CTA
One line of research is focused on repurposing antihypertensive ACE inhibitors and ARBs for Covid-19 based on their anti-inflammatory activity. Credit: Shutterstock